A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
NCT ID: NCT06926868
Last Updated: 2025-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2/PHASE3
500 participants
INTERVENTIONAL
2025-09-11
2030-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm A1
Iza-bren
Specified dose on specified days
Arm A2
Iza-bren
Specified dose on specified days
Arm B
Nab-paclitaxel
Specified dose on specified days
Paclitaxel
Specified dose on specified days
Capecitabine
Specified dose on specified days
Carboplatin
Specified dose on specified days
Gemcitabine
Specified dose on specified days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iza-bren
Specified dose on specified days
Nab-paclitaxel
Specified dose on specified days
Paclitaxel
Specified dose on specified days
Capecitabine
Specified dose on specified days
Carboplatin
Specified dose on specified days
Gemcitabine
Specified dose on specified days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with recurrent disease must have experienced disease relapse at least 6 months after finishing their last therapy with curative intent.
* Patients with TNBC must be considered ineligible for 1L chemotherapy combination treatment with an anti-PD-1 or an anti-PD-L1 due to either one of the following criteria:.
* Investigator-determined ineligibility based on PD-L1 negative disease determined and documented prior to trial screening as part of SoC.
* Has experienced disease relapse between 6 to 12 months after the completion of (neo)adjuvant therapy with an anti-PD(L)1.
* Has a severe auto-immune disease or other contraindication.
* Patients with ER-low, HER2-negative BC must be ineligible, in the opinion of the Investigator, for endocrine therapy-based treatments.
* No previous systemic therapy in the locally advanced, recurrent inoperable or metastatic setting (ie incurable setting).
* Measurable disease by CT or MRI as per RECIST v1.1.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bristol-Myers Squibb
INDUSTRY
SystImmune Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Bristol-Myers Squibb
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Local Institution - 0303
Hot Springs, Arkansas, United States
Helios Clinical Research
Cerritos, California, United States
Local Institution - 0307
Cerritos, California, United States
Local Institution - 0308
Cerritos, California, United States
Local Institution - 0309
Cerritos, California, United States
Local Institution - 0311
Long Beach, California, United States
Local Institution - 0290
Los Angeles, California, United States
Valkyrie Clinical Trials
Los Angeles, California, United States
Local Institution - 0353
Newport Beach, California, United States
Local Institution - 0358
Stanford, California, United States
Local Institution - 0289
Aurora, Colorado, United States
Local Institution - 0367
Denver, Colorado, United States
Medical Oncology Hematology Consultants, PA
Newark, Delaware, United States
Local Institution - 0282
Miami, Florida, United States
Local Institution - 0296
Pembroke Pines, Florida, United States
Local Institution - 0294
Atlanta, Georgia, United States
Local Institution - 0357
Atlanta, Georgia, United States
Local Institution - 0278
Chicago, Illinois, United States
Local Institution - 0280
Chicago, Illinois, United States
Decatur Memorial Hospital
Decatur, Illinois, United States
Local Institution - 0324
O'Fallon, Illinois, United States
Local Institution - 0286
Covington, Louisiana, United States
Local Institution - 0288
Boston, Massachusetts, United States
Local Institution - 0287
Boston, Massachusetts, United States
Local Institution - 0359
Detroit, Michigan, United States
Local Institution - 0313
Maple Grove, Minnesota, United States
Local Institution - 0372
Minneapolis, Minnesota, United States
Local Institution - 0284
Kansas City, Missouri, United States
Local Institution - 0312
New York, New York, United States
Local Institution - 0279
New York, New York, United States
Clinical Research Alliance
Westbury, New York, United States
White Plains Hospital
White Plains, New York, United States
Local Institution - 0276
Durham, North Carolina, United States
Local Institution - 0316
Eugene, Oregon, United States
Local Institution - 0356
Allentown, Pennsylvania, United States
Local Institution - 0310
Philadelphia, Pennsylvania, United States
Local Institution - 0360
Pittsburgh, Pennsylvania, United States
Local Institution - 0281
Greenville, South Carolina, United States
Local Institution - 0368
Abilene, Texas, United States
Local Institution - 0315
Austin, Texas, United States
Local Institution - 0314
Houston, Texas, United States
Local Institution - 0305
Tyler, Texas, United States
Local Institution - 0277
Midlothian, Virginia, United States
Local Institution - 0301
Roanoke, Virginia, United States
Local Institution - 0302
Winchester, Virginia, United States
Local Institution - 0011
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Local Institution - 0214
ABB, Buenos Aires F.D., Argentina
Local Institution - 0143
Córdoba, Córdoba Province, Argentina
Centro Privado de RMI Río Cuarto S.A. II
Río Cuarto, Córdoba Province, Argentina
Sanatorio Plaza
Rosario, Santa Fe Province, Argentina
Local Institution - 0345
Buenos Aires, , Argentina
Instituto Medico Especializado Alexander Fleming
Buenos Aires, , Argentina
Local Institution - 0317
Buenos Aires, , Argentina
Local Institution - 0346
Buenos Aires, , Argentina
Local Institution - 0348
Mendoza, , Argentina
Local Institution - 0170
Macquarie University, New South Wales, Australia
Royal Brisbane and Women's Hospital
Brisbane, Queensland, Australia
Grampians Health
Ballarat Central, Victoria, Australia
Local Institution - 0031
Heidelberg, Victoria, Australia
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
St. John of God Subiaco Hospital
Subiaco, Western Australia, Australia
Medizinische Universität Graz
Graz, Styria, Austria
Local Institution - 0268
Innsbruck, Tyrol, Austria
Local Institution - 0267
Salzburg, , Austria
Universitätsklinikum St. Pölten
Sankt Pölten, , Austria
Local Institution - 0269
Vienna, , Austria
Local Institution - 0187
Manaus, Amazonas, Brazil
Local Institution - 0147
Fortaleza, Ceará, Brazil
Local Institution - 0157
Vitória, Espírito Santo, Brazil
Local Institution - 0159
Curitiba, Paraná, Brazil
Local Institution - 0199
Porto Alegre, Rio Grande do Sul, Brazil
Local Institution - 0148
Barretos, São Paulo, Brazil
Local Institution - 0164
São José do Rio Preto, São Paulo, Brazil
Local Institution - 0153
Rio de Janeiro, , Brazil
Local Institution - 0144
São Paulo, , Brazil
Local Institution - 0149
São Paulo, , Brazil
Local Institution - 0218
Kelowna, British Columbia, Canada
Local Institution - 0217
Victoria, British Columbia, Canada
Local Institution - 0265
Ottawa, Ontario, Canada
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, Canada
McGill University Health Centre
Montreal, Quebec, Canada
Centre Intégré de Santé et de Services Sociaux de Lanaudière
Saint-Charles-Borromée, Quebec, Canada
Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CIUS
Sherbrooke, Quebec, Canada
Local Institution - 0016
Viña del Mar, Región de Valparaíso, Chile
Local Institution - 0138
Santiago, Santiago Metropolitan, Chile
Local Institution - 0021
Santiago, Santiago Metropolitan, Chile
Local Institution - 0017
Santiago, Santiago Metropolitan, Chile
Local Institution - 0018
Santiago, Santiago Metropolitan, Chile
Local Institution - 1001
Beijing, BEI, China
Local Institution - 0195
Medellín, Antioquia, Colombia
Local Institution - 0201
Rionegro, Antioquia, Colombia
Local Institution - 0194
Barranquilla, Atlántico, Colombia
Local Institution - 0182
Puerto Colombia, Atlántico, Colombia
Local Institution - 0181
Montería, COR, Colombia
Local Institution - 0327
Bogota, Cundinamarca, Colombia
Local Institution - 0183
Cali, Valle del Cauca Department, Colombia
Local Institution - 0349
Medellín, , Colombia
Local Institution - 0089
Bordeaux, Aquitaine, France
Local Institution - 0090
Lyon, Auvergne-Rhône-Alpes, France
Local Institution - 0272
Dijon, Côte-d'Or, France
Local Institution - 0098
Toulouse, Haute-Garonne, France
Local Institution - 0095
Montpellier, Hérault, France
Local Institution - 0099
Rennes, Ille-et-Vilaine, France
Local Institution - 0092
Saint-Herblain, Loire-Atlantique, France
Local Institution - 0091
Reims, Marne, France
Local Institution - 0097
Villejuif, Paris, France
Local Institution - 0093
Marseille, Provence-Alpes-Côte d'Azur Region, France
Local Institution - 0096
Clermont-Ferrand, Puy-de-Dôme, France
Local Institution - 0094
Lille, , France
Local Institution - 0088
Paris, , France
Klinikum Esslingen
Esslingen am Neckar, Baden-Wurttemberg, Germany
Local Institution - 0256
Augsburg, Bavaria, Germany
Rotkreuzklinikum München gemeinnützige GmbH
München, Bavaria, Germany
Local Institution - 0306
Frankfurt am Main, Hesse, Germany
Gemeinschaftspraxis für Hämatologie und Onkologie
Langen, Hesse, Germany
Local Institution - 0257
Hanover, Lower Saxony, Germany
Local Institution - 0293
Düsseldorf, North Rhine-Westphalia, Germany
Local Institution - 0263
Essen, North Rhine-Westphalia, Germany
Local Institution - 0254
Leipzig, Saxony, Germany
Local Institution - 0255
Lübeck, Schleswig-Holstein, Germany
Local Institution - 0261
Berlin, , Germany
Local Institution - 0260
Berlin, , Germany
Gynaekologisches Zentrum Bonn
Bonn, , Germany
Local Institution - 0258
Dresden, , Germany
Local Institution - 0262
Heidelberg, , Germany
Local Institution - 0291
Ulm, , Germany
Local Institution - 0043
Athens, Attikí (Region), Greece
Local Institution - 0042
Athens, Attikí, Greece
Local Institution - 0038
Athens, Attikí, Greece
Local Institution - 0086
Heraklion, Irakleío, Greece
Local Institution - 0337
Mumbai, Maharashtra, India
Local Institution - 0131
Mumbai, Maharashtra, India
Local Institution - 0134
Nagpur, Maharashtra, India
Local Institution - 0352
New Delhi, National Capital Territory of Delhi, India
Local Institution - 0266
New Delhi, National Capital Territory of Delhi, India
Local Institution - 0206
New Delhi, National Capital Territory of Delhi, India
Local Institution - 0125
Chennai, Tamil Nadu, India
Local Institution - 0130
Hyderabad, Telangana, India
Local Institution - 0133
Varanasi, Uttar Pradesh, India
Local Institution - 0186
Petah Tikva, Central District, Israel
Local Institution - 0044
Ramat Gan, Central District, Israel
Local Institution - 0047
Jerusalem, Jerusalem, Israel
Local Institution - 0048
Hadera, Northern District, Israel
Local Institution - 0123
Haifa, Northern District, Israel
Local Institution - 0051
Napoli, Campania, Italy
Local Institution - 0049
Bologna, Emilia-Romagna, Italy
Local Institution - 0057
Aviano, Friuli Venezia Giulia, Italy
Local Institution - 0054
Genoa, Liguria, Italy
Local Institution - 0053
Pontedera, Pisa, Italy
Local Institution - 0055
Prato, Tuscany, Italy
Local Institution - 0052
Milan, , Italy
Local Institution - 0058
Napoli, , Italy
Local Institution - 0061
Novara, , Italy
Local Institution - 0056
Padua, , Italy
Local Institution - 0062
Roma, , Italy
Local Institution - 0236
Nagoya, Aichi-ken, Japan
Local Institution - 0230
Chiba, Chiba, Japan
Local Institution - 0240
Matsuyama, Ehime, Japan
Local Institution - 0226
Otashi, Gunma, Japan
Local Institution - 0222
Sapporo, Hokkaido, Japan
Local Institution - 0232
Kanazawa, Ishikawa-ken, Japan
Local Institution - 0234
Isehara, Kanagawa, Japan
Local Institution - 0237
Yokohama, Kanagawa, Japan
Local Institution - 0246
Tsu, Mie-ken, Japan
Local Institution - 0223
Sendai, Miyagi, Japan
Local Institution - 0238
Suita, Osaka, Japan
Local Institution - 0227
Hidaka, Saitama, Japan
Local Institution - 0224
Ina-machi, Saitama, Japan
Local Institution - 0231
Bunkyo-ku, Tokyo, Japan
Local Institution - 0229
Chuo-ku, Tokyo, Japan
Local Institution - 0228
Koto, Tokyo, Japan
Local Institution - 0245
Shinagawa, Tokyo, Japan
Local Institution - 0233
Shinjuku-ku, Tokyo, Japan
Local Institution - 0242
Fukuoka, , Japan
Local Institution - 0225
Fukushima, , Japan
Local Institution - 0243
Hiroshima, , Japan
Local Institution - 0244
Kagoshima, , Japan
Local Institution - 0235
Kyoto, , Japan
Local Institution - 0241
Okayama, , Japan
Local Institution - 0239
Osaka, , Japan
Local Institution - 0177
Mexico City, DIF, Mexico
Local Institution - 0264
Tijuana, Estado de Baja California, Mexico
Local Institution - 0178
Guadalajara, Jalisco, Mexico
Local Institution - 0329
Mexico City, Mexico City, Mexico
Local Institution - 0175
Monterrey, Nuevo León, Mexico
Local Institution - 0176
Monterrey, Nuevo León, Mexico
Local Institution - 0355
Monterrey, Nuevo León, Mexico
Local Institution - 0173
Oaxaca City, Oaxaca, Mexico
Local Institution - 0179
Mérida, Yucatán, Mexico
Local Institution - 0174
Chihuahua City, , Mexico
Local Institution - 0189
Skórzewo, Greater Poland Voivodeship, Poland
Local Institution - 0074
Biała Podlaska, Lublin Voivodeship, Poland
Local Institution - 0072
Warsaw, Masovian Voivodeship, Poland
Local Institution - 0220
Warsaw, Masovian Voivodeship, Poland
Local Institution - 0076
Opole, Opole Voivodeship, Poland
Local Institution - 0221
Lodz, Łódź Voivodeship, Poland
Local Institution - 0198
Lisbon, Lisbon District, Portugal
Local Institution - 0106
Lisbon, Lisbon District, Portugal
Local Institution - 0109
Lisbon, Lisbon District, Portugal
Local Institution - 0124
Coimbra, , Portugal
Local Institution - 0141
Lisbon, , Portugal
Local Institution - 0111
Porto, , Portugal
Local Institution - 0253
Porto, , Portugal
Local Institution - 0212
Bistriţa, Bistrița-Năsăud County, Romania
Local Institution - 0213
Bucharest, București, Romania
Local Institution - 0079
Florești, Cluj, Romania
Local Institution - 0078
Craiova, Dolj, Romania
Local Institution - 0084
Ploieşti, Prahova, Romania
Local Institution - 0085
Timișoara, Timiș County, Romania
Local Institution - 0083
Bucharest, , Romania
Local Institution - 0077
Cluj-Napoca, , Romania
Local Institution - 0211
Dumbrăviţa, , Romania
S.C. Centrul de Oncologie Euroclinic S.R.L.
Iași, , Romania
Local Institution - 0080
Iași, , Romania
Local Institution - 0351
East London, Eastern Cape, South Africa
Local Institution - 0342
Parktown, Gauteng, South Africa
Local Institution - 0336
Pretoria, Gauteng, South Africa
Local Institution - 0341
Pretoria, Gauteng, South Africa
Local Institution - 0340
Soweto, Gauteng, South Africa
Local Institution - 0066
Goyang-si, Kyǒnggi-do, South Korea
Local Institution - 0067
Seongnam, Kyǒnggi-do, South Korea
Local Institution - 0068
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0063
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0071
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0064
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0065
Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Local Institution - 0069
Daegu, Taegu-Kwangyǒkshi, South Korea
Local Institution - 0105
A Coruña, A Coruña [La Coruña], Spain
Local Institution - 0100
Elche, Alicante, Spain
Local Institution - 0102
Barcelona, Barcelona [Barcelona], Spain
Local Institution - 0172
Hospitalet, Barcelona [Barcelona], Spain
Local Institution - 0140
Barcelona, Catalunya [Cataluña], Spain
Local Institution - 0139
Donostia / San Sebastian, Gipuzkoa, Spain
Local Institution - 0104
Madrid, Madrid, Comunidad de, Spain
Local Institution - 0108
Madrid, Madrid, Comunidad de, Spain
Local Institution - 0101
Málaga, Málaga, Spain
Local Institution - 0210
Valencia, Valenciana, Comunitat, Spain
Local Institution - 0107
Madrid, , Spain
Local Institution - 0103
Seville, , Spain
Local Institution - 0252
Malmo, Skåne Län [se-12], Sweden
Local Institution - 0026
Stockholm, Stockholms Län [se-01], Sweden
Local Institution - 0025
Uppsala, Uppsala Län [se-03], Sweden
Local Institution - 0024
Örebro, Örebro Län [se-18], Sweden
Universitetssjukhuset i Linköping
Linköping, Östergötlands Län [se-05], Sweden
Cantonal Hospital St.Gallen
Sankt Gallen, Canton of St. Gallen, Switzerland
CHUV (centre hospitalier universitaire vaudois)
Lausanne, Canton of Vaud, Switzerland
Brust-Zentrum
Zurich, , Switzerland
Local Institution - 0361
Adana, , Turkey (Türkiye)
Local Institution - 0362
Ankara, , Turkey (Türkiye)
Local Institution - 0364
Istanbul, , Turkey (Türkiye)
Local Institution - 0363
Istanbul, , Turkey (Türkiye)
Local Institution - 0323
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Local Institution - 0318
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Local Institution - 0322
Al Ain City, Abu Dhabi Emirate, United Arab Emirates
Local Institution - 0319
Abu Dhabi, , United Arab Emirates
The Royal Cornwall Hospital
Truro, England, United Kingdom
St Bartholomew's Hospital
London, London, City of, United Kingdom
Local Institution - 0204
London, London, City of, United Kingdom
Local Institution - 0209
London, London, City of, United Kingdom
Local Institution - 0171
Belfast, , United Kingdom
The Christie NHS Foundation Trust
Manchester, , United Kingdom
Local Institution - 0006
Nottingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
BMS Study Connect Contact Center www.BMSStudyConnect.com
Role: CONTACT
Phone: 855-907-3286
Email: [email protected]
First line of the email MUST contain NCT # and Site #.
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Site 0303
Role: primary
Omkar Marathe, Site 0328
Role: primary
Site 0290
Role: primary
David Berz, Site 0283
Role: primary
Site 0353
Role: primary
Site 0358
Role: primary
Site 0289
Role: primary
Site 0367
Role: primary
Jamal Misleh, Site 0304
Role: primary
Site 0282
Role: primary
Site 0296
Role: primary
Site 0294
Role: primary
Site 0357
Role: primary
Site 0280
Role: primary
James Wade, Site 0275
Role: primary
Site 0286
Role: primary
Site 0288
Role: primary
Site 0287
Role: primary
Site 0359
Role: primary
Site 0313
Role: primary
Site 0372
Role: primary
Site 0284
Role: primary
Site 0279
Role: primary
James D'Olimpio, Site 0295
Role: primary
Dan Costin, Site 0285
Role: primary
Site 0276
Role: primary
Site 0316
Role: primary
Site 0356
Role: primary
Site 0310
Role: primary
Site 0360
Role: primary
Site 0281
Role: primary
Site 0368
Role: primary
Site 0315
Role: primary
Site 0314
Role: primary
Site 0305
Role: primary
Site 0277
Role: primary
Site 0301
Role: primary
Site 0302
Role: primary
Site 0011
Role: primary
Site 0214
Role: primary
Site 0143
Role: primary
Alejo Lingua, Site 0137
Role: primary
Miriam Raimondo, Site 0142
Role: primary
Site 0345
Role: primary
Adrian Nervo, Site 0012
Role: primary
Site 0317
Role: primary
Site 0346
Role: primary
Site 0348
Role: primary
Site 0170
Role: primary
Po-ling Inglis, Site 0035
Role: primary
LeeNa Teo, Site 0197
Role: primary
Site 0031
Role: primary
Peter Savas, Site 0274
Role: primary
Daphne Tsoi, Site 0028
Role: primary
Vassiliki Kolovetsiou Kreiner, Site 0292
Role: primary
Site 0268
Role: primary
Site 0267
Role: primary
Maria Gold, Site 0270
Role: primary
Site 0269
Role: primary
Site 0187
Role: primary
Site 0147
Role: primary
Site 0157
Role: primary
Site 0159
Role: primary
Site 0199
Role: primary
Site 0148
Role: primary
Site 0164
Role: primary
Site 0153
Role: primary
Site 0144
Role: primary
Site 0149
Role: primary
Site 0218
Role: primary
Site 0217
Role: primary
Site 0265
Role: primary
Danielle Charpentier, Site 0215
Role: primary
Jamil Asselah, Site 0219
Role: primary
Angélique Brunot, Site 0350
Role: primary
Michel Pavic, Site 0216
Role: primary
Site 0016
Role: primary
Site 0138
Role: primary
Site 0021
Role: primary
Site 0017
Role: primary
Site 0018
Role: primary
Site 1001
Role: primary
Site 0201
Role: primary
Site 0194
Role: primary
Site 0181
Role: primary
Site 0327
Role: primary
Site 0183
Role: primary
Site 0349
Role: primary
Site 0089
Role: primary
Site 0090
Role: primary
Site 0272
Role: primary
Site 0098
Role: primary
Site 0095
Role: primary
Site 0099
Role: primary
Site 0092
Role: primary
Site 0097
Role: primary
Site 0093
Role: primary
Site 0096
Role: primary
Site 0094
Role: primary
Alexander Hein, Site 0320
Role: primary
Site 0256
Role: primary
Michael Braun, Site 0271
Role: primary
Site 0306
Role: primary
Andreas Köhler, Site 0333
Role: primary
Site 0257
Role: primary
Site 0293
Role: primary
Site 0263
Role: primary
Site 0254
Role: primary
Site 0255
Role: primary
Site 0261
Role: primary
Site 0260
Role: primary
Christian Kurbacher, Site 0259
Role: primary
Site 0258
Role: primary
Site 0262
Role: primary
Site 0291
Role: primary
Site 0043
Role: primary
Site 0042
Role: primary
Site 0038
Role: primary
Site 0086
Role: primary
Site 0131
Role: primary
Site 0134
Role: primary
Site 0352
Role: primary
Site 0266
Role: primary
Site 0206
Role: primary
Site 0125
Role: primary
Site 0130
Role: primary
Site 0133
Role: primary
Site 0186
Role: primary
Site 0044
Role: primary
Site 0047
Role: primary
Site 0048
Role: primary
Site 0123
Role: primary
Site 0051
Role: primary
Site 0049
Role: primary
Site 0057
Role: primary
Site 0054
Role: primary
Site 0053
Role: primary
Site 0055
Role: primary
Site 0052
Role: primary
Site 0058
Role: primary
Site 0061
Role: primary
Site 0056
Role: primary
Site 0062
Role: primary
Site 0236
Role: primary
Site 0230
Role: primary
Site 0240
Role: primary
Site 0226
Role: primary
Site 0222
Role: primary
Site 0232
Role: primary
Site 0234
Role: primary
Site 0237
Role: primary
Site 0246
Role: primary
Site 0223
Role: primary
Site 0238
Role: primary
Site 0227
Role: primary
Site 0224
Role: primary
Site 0231
Role: primary
Site 0229
Role: primary
Site 0228
Role: primary
Site 0245
Role: primary
Site 0233
Role: primary
Site 0242
Role: primary
Site 0225
Role: primary
Site 0243
Role: primary
Site 0244
Role: primary
Site 0235
Role: primary
Site 0241
Role: primary
Site 0239
Role: primary
Site 0177
Role: primary
Site 0264
Role: primary
Site 0178
Role: primary
Site 0329
Role: primary
Site 0175
Role: primary
Site 0176
Role: primary
Site 0173
Role: primary
Site 0179
Role: primary
Site 0174
Role: primary
Site 0189
Role: primary
Site 0074
Role: primary
Site 0072
Role: primary
Site 0220
Role: primary
Site 0076
Role: primary
Site 0221
Role: primary
Site 0198
Role: primary
Site 0106
Role: primary
Site 0109
Role: primary
Site 0124
Role: primary
Site 0141
Role: primary
Site 0111
Role: primary
Site 0253
Role: primary
Site 0212
Role: primary
Site 0213
Role: primary
Site 0079
Role: primary
Site 0078
Role: primary
Site 0084
Role: primary
Site 0085
Role: primary
Site 0083
Role: primary
Site 0077
Role: primary
Site 0211
Role: primary
Simona Volovat, Site 0081
Role: primary
Site 0080
Role: primary
Site 0351
Role: primary
Site 0342
Role: primary
Site 0336
Role: primary
Site 0341
Role: primary
Site 0340
Role: primary
Site 0066
Role: primary
Site 0067
Role: primary
Site 0068
Role: primary
Site 0063
Role: primary
Site 0071
Role: primary
Site 0064
Role: primary
Site 0065
Role: primary
Site 0069
Role: primary
Site 0105
Role: primary
Site 0100
Role: primary
Site 0102
Role: primary
Site 0172
Role: primary
Site 0140
Role: primary
Site 0139
Role: primary
Site 0104
Role: primary
Site 0108
Role: primary
Site 0101
Role: primary
Site 0210
Role: primary
Site 0107
Role: primary
Site 0103
Role: primary
Site 0252
Role: primary
Site 0026
Role: primary
Site 0025
Role: primary
Site 0024
Role: primary
Ahmed Albu -Kareem, Site 0247
Role: primary
Jens Huober, Site 0250
Role: primary
Athina Stravodimou, Site 0249
Role: primary
Elena Kralidis, Site 0251
Role: primary
Site 0361
Role: primary
Site 0362
Role: primary
Site 0364
Role: primary
Site 0363
Role: primary
Site 0323
Role: primary
Site 0318
Role: primary
Site 0322
Role: primary
Site 0319
Role: primary
Alastair Thomson, Site 0208
Role: primary
Peter Schmid, Site 0004
Role: primary
Site 0209
Role: primary
Site 0171
Role: primary
Anne Armstrong, Site 0001
Role: primary
Site 0006
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
BMS Clinical Trial Information
BMS Clinical Trial Patient Recruiting
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-519871-24
Identifier Type: OTHER
Identifier Source: secondary_id
U1111-1316-1533
Identifier Type: OTHER
Identifier Source: secondary_id
CA244-0008
Identifier Type: -
Identifier Source: org_study_id